Skip to main content
Premium Trial:

Request an Annual Quote

Due Diligence and Deception

A post by Vivian Cheng at Science Progress chronicles a recent accusation of data-falsification in a study on a bone-growth treatment. Timothy Kuklo, a former Army orthopedic surgeon now at Washington University in St. Louis authored an article in the British Journal of Bone and Joint Surgery that said Medtronic's Infuse was better at treating severe leg injuries suffered by soldiers than traditional therapies. An investigation by the Army, reported on by the New York Times, concluded that Kuklo forged the signatures of four Army doctors -- none of whom saw the article prior to publication. The paper was retracted and Kuklo banned from future contributions. "The Walter Reed episode also shows how medical journals may fail to conduct adequate due diligence on the studies they publish — information that other doctors rely on for guidance," says the Times article by Barry Meier and Duff Wilson.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.